---
title: Aldosterone-antagonists
---
# Aldosterone-antagonists

* Add after RASi and bB if adeq. renal fxn and w/o hyperkalemia

* 25–30% ↓ mort. in NYHA II–IV & EF ≤35% (NEJM 2011;364:11)

* 15% ↓ mort. in HF post-MI, EF ≤40% (EPHESUS, NEJM 2003;348:1309)

* Watch for ↑ K. Do not use if GFR <30 or K ≥5
